Abstract:Background: While utilization of minimally invasive surgery and sentinel lymph node biopsy have increased considerably over time for surgical management of early-stage uterine cancer, practice varies significantly in the United States, with disparities among low-volume centers and patients of Black race. A significant number of counties in the US are without a gynecologic oncologist, and almost half of counties with the highest gynecologic cancer rates lack a local gynecologic oncologist. Objective: To evaluate relationships of distance traveled and proximity to gynecologic oncologists with receipt of and racial disparities in the quality of surgical care in patients undergoing hysterectomy for nonmetastatic uterine cancer. Study design: Patients who underwent hysterectomy for nonmetastatic uterine cancer in Kentucky, Maryland, Florida, and North Carolina were identified in 2012-2018 State Inpatient Database and State Ambulatory Surgery Services Database files. County-to-county distances were used for distances traveled and to nearest gynecologic oncologist. Factors associated with receipt of minimally invasive surgery and lymph node dissection were analyzed using multivariable logistic regression models including assessment for interactions of travel for surgery with patient race. Results: Among 21,837 cases, 45.5% lived in a county without a gynecologic oncologist; 55.5% overall traveled to another county for surgery, including 88% of those lacking a local gynecologic oncologist. Patients lacking local access to a gynecologic oncologist in their county who did not travel for surgery were more likely to receive open surgery and no lymph node dissection, and those in counties without access in any surrounding county were even more likely. Among patients in counties without a gynecologic oncologist, those who traveled for surgery had similar likelihood of minimally invasive surgery (71%) but greater likelihood of lymph node dissection (64.7% vs 57.2%) compared to non-travelers. Among counties without a gynecologic oncologist, longer distance traveled was associated with receipt of lymph node assessment. Compared to non-Black patients, Black patients were less likely to undergo minimally invasive surgery (57.0% vs 74.1%). In adjusted regression models controlling for a diagnosis of fibroids, Black race was an independent risk factor for receipt of open surgery. There was a significant interaction of Black race and travel for surgery, with Black patients who lived in counties without a gynecologic oncologist who did not travel facing incrementally lower likelihood of receiving minimally invasive surgery (OR=0.57 vs non-Black patients who traveled for surgery; OR=0.60 as interaction term; p<0.001 for both). Similar disparities in surgical quality by race were noted for Black patients who lived in counties with a gynecologic oncologist who traveled out of county for surgery. Conclusions: Patients, particularly those of Black race, who lack local access to gynecologic oncologist specialty care benefit from traveling to specialty centers to ensure access to high-quality surgery for nonmetastatic uterine cancer. Further work is needed to ensure equitable and universal access to high-quality care through patient travel or specialist outreach.

Association of travel time, patient characteristics, and hospital quality with patient mobility for breast cancer surgery: A national population‐based study

Travel burden and bypassing closest site for surgical cancer treatment for urban and rural oncology patients

The impact of transportation mode, socioeconomic deprivation and rurality on travel times to radiotherapy and surgical services for patients with prostate cancer: A national population-based evaluation

Is Centralisation of Cancer Services Associated With Under‐Treatment of Patients With High‐Risk Prostate Cancer?—A National Population‐Based Study

Geographic and racial disparities in the quality of surgical care among patients with nonmetastatic uterine cancer

Travel Burden to Cancer Screening and Treatment Facilities Among Washington Women: Data From an Integrated Healthcare Delivery System

Effect of rurality and travel distance on contralateral prophylactic mastectomy for unilateral breast cancer

Distance to Treatment With Radical Cystectomy in a Rural State: Long Car Rides, Equivalent Outcomes

Abstract A165: Impact of travel distance and regional factors on five-year survival in gynecologic cancer patients: Analysis of National and Comprehensive Cancer Center data

Survival Disparities among Cancer Patients Based on Mobility Patterns: A Population-Based Study

Relationship between breast reconstruction and travel distance

Bayesian Spatio-Temporal Multilevel Modelling of Patient-Reported Quality of Life following Prostate Cancer Surgery

Rural-urban differences in the association between individual, facility, and clinical characteristics and travel time for cancer treatment

Accessing surgical care for pancreaticoduodenectomy: Patient variation in travel distance and choice to bypass hospitals to reach higher volume centers

The Effect on Travel Distance of a Statewide Regionalization Policy for Initial Breast Cancer Surgery

Factors associated with delay in breast biopsy in a vulnerable population.

Causes of Unwarranted Variation and Disparity in Breast Cancer Management in Regional and Rural Area

Travel Times for Screening Mammography: Impact of Geographic Expansion by a Large Academic Health System

Breast cancer stage at diagnosis and geographic access to mammography screening (New Hampshire, 1998-2004)

Abstract C124: Past Medical Utilization Patterns as a Key Determinant of Hospital Choice for Cancer Patients in Non-Residential Areas: A National Health Insurance Database Study in Korea

A qualitative study on the impact of long-distance travel for gynecologic cancer care